Fundz

Rafael Gabay Acquires Securities Of Im Cannabis Corp.

PRIVATEJan 17, 2023

Acquiring Company

RAFAEL GABAY

Acquired Company

IM Cannabis Corp

HerzliyaOtherManufacturingBiotechnologyFood and BeverageCommunity And LifestyleHealth CareMedicalCannabis

Description

Rafael Gabay (the "Acquiror"), CEO, director and founder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE: IMCC) (NASDAQ: IMCC), announces that he has acquired an aggregate of 303,295 common shares in the capital of the Company ("Common Shares") and 303,295 Warrants (as hereinafter defined) pursuant to a non-brokered private placement offering of units ("Units") of the Company (the "Offering").

Quick answer

RAFAEL GABAY is acquiring IM Cannabis Corp, announced January 17, 2023.

How much did RAFAEL GABAY pay for IM Cannabis Corp?
The deal value was not disclosed.
What does RAFAEL GABAY do?
Gabay & Gottlieb is a state-of-the-art cosmetic surgery center proudly serving the Great Philadelphia Area and beyond.
Where are RAFAEL GABAY and IM Cannabis Corp based?
IM Cannabis Corp is based in Herzliya, Tel Aviv, Israel.

Source: Fundz verified event record.

Other recent acquisitions in Food and Beverage and Community And Lifestyle

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at RAFAEL GABAY, and when

When RAFAEL GABAY changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day RAFAEL GABAY raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RAFAEL GABAY, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RAFAEL GABAY. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RAFAEL GABAY

About

Gabay & Gottlieb is a state-of-the-art cosmetic surgery center proudly serving the Great Philadelphia Area and beyond. Schedule a consultation with our board-certified team today!

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RAFAEL GABAY makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for RAFAEL GABAY's next move

Learn about Strategic plan

Frequently asked

Who acquired IM Cannabis Corp?

IM Cannabis Corp was acquired by RAFAEL GABAY. The deal was reported on January 17, 2023. Gabay & Gottlieb is a state-of-the-art cosmetic surgery center proudly serving the Great Philadelphia Area and beyond. Schedule a consultation with our board-certified team today! RAFAEL GABAY is privately held.

When did RAFAEL GABAY acquire IM Cannabis Corp?

RAFAEL GABAY's acquisition of IM Cannabis Corp was reported on January 17, 2023. Rafael Gabay (the "Acquiror"), CEO, director and founder of IM Cannabis Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does IM Cannabis Corp do?

IM Cannabis Corp. (IMC) is a leading medical cannabis company with operations in Israel and Germany. It is publicly traded (IMCC), operating in Other, and is based in Herzliya.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.